is compounded semaglutide really a bad thing Mix-it-yourself Wegovy? Some try risky sources for obesity drugs The era of $199 copycat

How to Make Smoothies Part of Your Daily Routine Consistency matters more than complexity

With the motivation to Eat, Inject, and Repeat that The Economist described in its cover story from 2nd March 2023, the story talks about the fast market growth of the GLP-1s as shown in the line chart here, with the forecasted market for these drugs reaching $150bn by 2031 about the market for todays cancer therapies

Please, wait

Semaglutide also carries a warning about potential worsening of diabetic retinopathy complications, particularly in patients with pre-existing retinopathy

Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome Related to Obesity